Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient

Pediatr Nephrol. 2025 Feb;40(2):389-391. doi: 10.1007/s00467-024-06493-4. Epub 2024 Sep 4.

Abstract

We report on a 14-year-old girl who developed post-transplantation smooth muscle tumours (PTSMT) located in the spleen, lungs, liver, and central nervous system (CNS), 4 years after kidney transplantation. She was asymptomatic, and the disease was detected during the work-up for a urinary tract infection. Diagnosis was performed by the analysis of a tissue specimen, through the biopsy of a lung tumour, which revealed a proliferation of spindle-shaped cells which were positive for actin and vimentin. In situ hybridization studies were positive for Epstein-Barr virus, and her serologic status was negative prior to transplantation. We reduced immunosuppression by stopping mycophenolate and switching tacrolimus for sirolimus. After 18 months of follow-up, she remains asymptomatic, and the CNS tumour reduced its diameter from 24 × 21 mm to 14 × 13 mm. PTSMT should be considered in the differential diagnosis of transplanted patients who develop neoplastic complications associated with immunosuppression.

Keywords: Epstein-Barr virus; Kidney transplantation; Post-transplantation smooth muscle tumour.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / diagnosis
  • Epstein-Barr Virus Infections* / virology
  • Female
  • Herpesvirus 4, Human* / isolation & purification
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Immunosuppressive Agents* / therapeutic use
  • Kidney Transplantation* / adverse effects
  • Lung Neoplasms / surgery
  • Smooth Muscle Tumor* / diagnosis
  • Smooth Muscle Tumor* / etiology
  • Smooth Muscle Tumor* / pathology
  • Smooth Muscle Tumor* / virology

Substances

  • Immunosuppressive Agents